New Vaccine Teaches Immune System to Battle Melanoma

Illinois researchers are conducting a Phase 1 clinical trial to test the ability of a new vaccine to teach the human immune system to fight melanoma. Incidence of this type of cancer has been increasing for decades. Loyola University Medical Center scientists remove killer T cells from a patient. The goal of the procedure is for the genetically engineered cells to recognize melanoma cells as abnormal structures, then mount an attack on them and destroy them.



via Health News Headlines - Yahoo! News http://news.yahoo.com/vaccine-teaches-immune-system-battle-melanoma-161100552.html